 
									
								
									$doc.title
									
... abusers (POAs) in December 2010 and were granted approval to enroll three POAs on May 26, 2011. IRB approval for the remaining eighteen POAs is contingent upon the IRB's satisfaction with the participation report of these initial3 POAs. Since recruitment efforts began in July of2011, we've had eight ...
                        	... abusers (POAs) in December 2010 and were granted approval to enroll three POAs on May 26, 2011. IRB approval for the remaining eighteen POAs is contingent upon the IRB's satisfaction with the participation report of these initial3 POAs. Since recruitment efforts began in July of2011, we've had eight ...
									ICCAC Sept 2015 draft
									
... cell and gene therapy, biomaterials, tissue engineering, organ preservation, robotics …) have been developed and are addressed. For the first time, ICCAC was honored to participate in this year’s conference and held a European VAD Coordinator Meeting ...
                        	... cell and gene therapy, biomaterials, tissue engineering, organ preservation, robotics …) have been developed and are addressed. For the first time, ICCAC was honored to participate in this year’s conference and held a European VAD Coordinator Meeting ...
									Guide for Communicable Diseases Public Health Research Grant
									
... Resubmission refers to proposals resubmitted after earlier unsuccessful application(s). It is not a rewritten proposal from a new perspective. If more than 50% of the proposal is to be revised, it should be submitted as a new application. Please note that resubmission attempts are capped at two time ...
                        	... Resubmission refers to proposals resubmitted after earlier unsuccessful application(s). It is not a rewritten proposal from a new perspective. If more than 50% of the proposal is to be revised, it should be submitted as a new application. Please note that resubmission attempts are capped at two time ...
									early management of infants with hypoplastic left heart syndrome
									
... 4. Stable patients who are not acidotic, with a normal lactate, with secure central or peripheral intravenous access (two), may be transferred to 7West after review by the ICU consultant. 5. Surgery This will, where possible, be planned for day 3 or 4 of life, but earlier if there is circulatory ins ...
                        	... 4. Stable patients who are not acidotic, with a normal lactate, with secure central or peripheral intravenous access (two), may be transferred to 7West after review by the ICU consultant. 5. Surgery This will, where possible, be planned for day 3 or 4 of life, but earlier if there is circulatory ins ...
									Twenty Statistical Errors Even YOU Can Find in
									
... a sample and sometimes to a population. To avoid confusion, the mean and standard deviation are the preferred summary statistics for (normally distributed) data, and the mean and 95% confidence interval are preferred for reporting an estimate and its measure of ...
                        	... a sample and sometimes to a population. To avoid confusion, the mean and standard deviation are the preferred summary statistics for (normally distributed) data, and the mean and 95% confidence interval are preferred for reporting an estimate and its measure of ...
									ACR Practice Guideline for Communication of Diagnostic Imaging
									
... practitioners in providing appropriate radiologic care for patients. They are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care. For these reasons and those set forth below, the American College of Radiology cautions ...
                        	... practitioners in providing appropriate radiologic care for patients. They are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care. For these reasons and those set forth below, the American College of Radiology cautions ...
									[ICH E2F] [MODEL DSUR – Non
									
... some evidence of the biological activity of VGF-2, as indicated by improvement in the 6minute walk test (6-MWT). Because the VGF-R receptor is thought to be up-regulated during ischemia, each subject will receive 3 infusions of VGF-2 (or placebo) during treadmill exercise (Days 1, 3, and 5, see prot ...
                        	... some evidence of the biological activity of VGF-2, as indicated by improvement in the 6minute walk test (6-MWT). Because the VGF-R receptor is thought to be up-regulated during ischemia, each subject will receive 3 infusions of VGF-2 (or placebo) during treadmill exercise (Days 1, 3, and 5, see prot ...
									The Rockefeller University Center for Clinical and Translational
									
... Confidentiality – is adequately addressed with anonymous survey design. Survey data quality – The survey would benefit from another round of refinement. For example: ...
                        	... Confidentiality – is adequately addressed with anonymous survey design. Survey data quality – The survey would benefit from another round of refinement. For example: ...
									Slide 1
									
... also give consent (although parents will ideally be involved) For Example: - Blood transfusion or chemotherapy.  In other cases where a child is not deemed competent, someone with parental responsibility must give consent on the child’s behalf, unless they cannot be reached in an emergency. For exa ...
                        	... also give consent (although parents will ideally be involved) For Example: - Blood transfusion or chemotherapy.  In other cases where a child is not deemed competent, someone with parental responsibility must give consent on the child’s behalf, unless they cannot be reached in an emergency. For exa ...
									Effective Treatment of Seborrheic Dermatitis Using a Low Dose, Oral
									
... names by the study monitor and randomized in blocks of four. The study investigator was given a list of the randomized, coded dose groups. As patients entered into the study, they were assigned, with no regard to individual characteristics, to the next available randomized, coded dose group on the l ...
                        	... names by the study monitor and randomized in blocks of four. The study investigator was given a list of the randomized, coded dose groups. As patients entered into the study, they were assigned, with no regard to individual characteristics, to the next available randomized, coded dose group on the l ...
									The Sixth Annual - Northwestern Oklahoma State University
									
... subjects; 3 males and 3 females, all of college age, but of different lifestyles (some play sports while others are sedentary). This experiment was carried out in 24 trials in which a trial is where the resting heart rate of an experimental subject is recorded and then measured again while listening ...
                        	... subjects; 3 males and 3 females, all of college age, but of different lifestyles (some play sports while others are sedentary). This experiment was carried out in 24 trials in which a trial is where the resting heart rate of an experimental subject is recorded and then measured again while listening ...
									Radiation Oncology - The American Board of Radiology
									
... levels, and all promising routes for innovation should be encouraged. At the same time, the committee formulated a set of ten simple rules, or general principles, to inform efforts to redesign the healthcare system. These rules are: Care is based on continuous healing relationships. Patients should ...
                        	... levels, and all promising routes for innovation should be encouraged. At the same time, the committee formulated a set of ten simple rules, or general principles, to inform efforts to redesign the healthcare system. These rules are: Care is based on continuous healing relationships. Patients should ...
									Strategies for Cancer Clinical Trials Education and Awareness
									
... – Overcome barriers to enrollment in trials – Help people make informed decisions about cancer treatment and prevention options – Make community aware of the option of participation in a clinical trial ...
                        	... – Overcome barriers to enrollment in trials – Help people make informed decisions about cancer treatment and prevention options – Make community aware of the option of participation in a clinical trial ...
									Calvary Centre for Palliative Care Research The EMK
									
...  A correlation analysis will be conducted with all the self efficacy questionnaire items 1-12 to identify which items appear to be measuring the same constructs.  Descriptive factor analysis will be conducted with items 1-12 which look at feelings about medication management and perceived ...
                        	...  A correlation analysis will be conducted with all the self efficacy questionnaire items 1-12 to identify which items appear to be measuring the same constructs.  Descriptive factor analysis will be conducted with items 1-12 which look at feelings about medication management and perceived ...
									General considerations - Society of NeuroInterventional Surgery
									
... study should be permanently recorded and should be of sufficient detail to characterize the extent of vascular disease that might contribute to the patient’s clinical syndrome, treatment effects and post-treatment clinical course. This frequently requires angiographic study of adjacent and remote ves ...
                        	... study should be permanently recorded and should be of sufficient detail to characterize the extent of vascular disease that might contribute to the patient’s clinical syndrome, treatment effects and post-treatment clinical course. This frequently requires angiographic study of adjacent and remote ves ...
									Excellent translational research in oncology: A journey towards
									
... definitions currently exist (Woolf, 2008; Rajan et al., 2012). However, only few cover the complete cancer research continuum from bench to bedside and vice versa (Rajan et al., 2012). One definition (National Institutes of Health, 2014) that does, was put forward by the staff of the National Cancer ...
                        	... definitions currently exist (Woolf, 2008; Rajan et al., 2012). However, only few cover the complete cancer research continuum from bench to bedside and vice versa (Rajan et al., 2012). One definition (National Institutes of Health, 2014) that does, was put forward by the staff of the National Cancer ...
									Advert (TENDER_i4i_ADVT_Call 3)
									
... 28 October 2011 - Patients are set to benefit as researchers are invited to submit proposals to develop innovative healthcare products to improve the diagnosis, treatment and prevention of disease in the NHS. The National Institute for Health Research (NIHR) Invention for Innovation (i4i) programme ...
                        	... 28 October 2011 - Patients are set to benefit as researchers are invited to submit proposals to develop innovative healthcare products to improve the diagnosis, treatment and prevention of disease in the NHS. The National Institute for Health Research (NIHR) Invention for Innovation (i4i) programme ...
									Fall 2011 - California Retina Research Foundation
									
... Steinle says he felt very fortunate to have been given an inside perspective on such a groundbreaking clinical trial. He notes, “Worldwide, every retina specialist has been eagerly awaiting the results of this trial. Aside from the far-reaching implication to the field of ophthalmology, CATT will re ...
                        	... Steinle says he felt very fortunate to have been given an inside perspective on such a groundbreaking clinical trial. He notes, “Worldwide, every retina specialist has been eagerly awaiting the results of this trial. Aside from the far-reaching implication to the field of ophthalmology, CATT will re ...
									Chapter 18 FDA-Regulated Research
									
... before the trials are completed. When there is no satisfactory standard treatment for a serious, life-threatening, or debilitating condition, the FDA has a mechanism that allows expanded access to investigational drugs before the clinical trials are complete. When no satisfactory alternative treatme ...
                        	... before the trials are completed. When there is no satisfactory standard treatment for a serious, life-threatening, or debilitating condition, the FDA has a mechanism that allows expanded access to investigational drugs before the clinical trials are complete. When no satisfactory alternative treatme ...
									Institutional Integrity and Organizational Ethics
									
... live a moral life and make good ethical decisions? n What are my duties and obligations to other individuals whose life and well-being may be affected by my actions? n What do I owe the common good or the public interest, in my life as a member of society? n ...
                        	... live a moral life and make good ethical decisions? n What are my duties and obligations to other individuals whose life and well-being may be affected by my actions? n What do I owe the common good or the public interest, in my life as a member of society? n ...
									Medical Research: A Consumer`s Guide for Participation
									
... Health (NIH). Several years ago, HHS developed regulations for research supported by HHS agencies. Many other government agencies now use this regulation, called the “Common Rule,” to protect research volunteers. The Common Rule codifies three basic ethical requirements for conducting human research ...
                        	... Health (NIH). Several years ago, HHS developed regulations for research supported by HHS agencies. Many other government agencies now use this regulation, called the “Common Rule,” to protect research volunteers. The Common Rule codifies three basic ethical requirements for conducting human research ...
									Excluding Older, Sicker Patients from Clinical Trials: Issues
									
... There is general agreement in the scientific and clinical communities that underrepresentation of older adults and people with multiple chronic conditions is problematic. However, there is less agreement about the best approaches to address this problem. Proposals to expand participation in clinical ...
                        	... There is general agreement in the scientific and clinical communities that underrepresentation of older adults and people with multiple chronic conditions is problematic. However, there is less agreement about the best approaches to address this problem. Proposals to expand participation in clinical ...
									NCCP Chemotherapy Protocol Bosutinib Monotherapy INDICATIONS FOR USE:
									
... Interrupt bosutinib therapy until recovery to ≤ 2.5 x ULN. Therapy may be resumed at 400 mg once daily ...
                        	... Interrupt bosutinib therapy until recovery to ≤ 2.5 x ULN. Therapy may be resumed at 400 mg once daily ...
									Animal Testing and Clinical Trials
									
... only variety of HIV types but also rapidly change of them, no specific treatment for HIV/AIDS patients are completely developed. Normally, the testing of new drug(s) and vaccine to prevent or cure this dreadful disease has been initially in vitro follow by in vivo and finally study in humans. Hence, ...
                        	... only variety of HIV types but also rapidly change of them, no specific treatment for HIV/AIDS patients are completely developed. Normally, the testing of new drug(s) and vaccine to prevent or cure this dreadful disease has been initially in vitro follow by in vivo and finally study in humans. Hence, ...
 
									 
									 
									 
									 
									 
									![[ICH E2F] [MODEL DSUR – Non](http://s1.studyres.com/store/data/023281451_1-209fb32ce5955d2c7e6ff8f85a13c720-300x300.png) 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									